Marrone Bio Innovations (NASDAQ:MBII – Get Rating) released its earnings results on Wednesday. The basic materials company reported ($0.04) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02), MarketWatch Earnings reports. Marrone Bio Innovations had a negative return on equity of 65.95% and a negative net margin of 47.07%. During […]
StockNews.com initiated coverage on shares of Marrone Bio Innovations (NASDAQ:MBII – Get Rating) in a research note issued to investors on Friday. The firm issued a sell rating on the basic materials company’s stock. Separately, Zacks Investment Research raised Marrone Bio Innovations from a sell rating to a hold rating in a report on Friday. […]